Downregulation of increased CD95 (APO-1/Fas) ligand in T cells from human immunodeficiency virus-type 1-infected children after antiretroviral therapy

Blood. 1997 Jul 15;90(2):886-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • Child
  • Didanosine / therapeutic use
  • Drug Therapy, Combination
  • Fas Ligand Protein
  • Gene Expression Regulation / drug effects
  • HIV Infections / blood
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • HIV-1* / isolation & purification
  • Humans
  • Lamivudine / therapeutic use
  • Membrane Glycoproteins / biosynthesis*
  • RNA, Messenger / biosynthesis
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • Time Factors
  • Transcription, Genetic / drug effects*
  • Zalcitabine / therapeutic use
  • Zidovudine / therapeutic use
  • fas Receptor / immunology*

Substances

  • Anti-HIV Agents
  • FASLG protein, human
  • Fas Ligand Protein
  • Membrane Glycoproteins
  • RNA, Messenger
  • Reverse Transcriptase Inhibitors
  • fas Receptor
  • Lamivudine
  • Zidovudine
  • Zalcitabine
  • Didanosine